Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial

Autor: Montejano R, de la Calle-Prieto F, Velasco M, Guijarro C, Queiruga-Parada J, Jimenez-Gonzalez M, Gonzalez-Ruano P, Martinez P, Goikoetxea A, Ibarrola M, Ciudad M, Gutierrez A, Torralba M, Diaz-Brasero A, Ryan P, Marcelo C, Diez C, Ibarra S, Merino E, Estrada V, Marcos J, Novella M, Rivera M, Ruiz-Munoz M, de Miguel M, Soler L, Del Alamo M, Moreno S, Carcas A, Borobia A, Arribas J

Publikováno v: CLINICAL INFECTIOUS DISEASES
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

Background This study was designed to evaluate if patients with high risk for severe coronavirus disease 2019 (COVID-19) would benefit from treatment with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) followed by baricitinib in case of hypoxe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::32ff556f0cb2bb5f65610efa240ae460
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9156

Additional file 2 of A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

Autor: García-García, I., Guerra-García, P., Ferreras, C., Borobia, A. M., Carcas, A. J., Queiruga-Parada, J., Vicario, J. L., Mirones, I., Solano, C., Eguizabal, C., Soria, B., Pérez-Martínez, A.

Additional file 2. Informed Consent v4.0 18th March 2021.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41698cc35b480e00f4f132171a52797c

Additional file 3 of A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

Autor: García-García, I., Guerra-García, P., Ferreras, C., Borobia, A. M., Carcas, A. J., Queiruga-Parada, J., Vicario, J. L., Mirones, I., Solano, C., Eguizabal, C., Soria, B., Pérez-Martínez, A.

Additional file 3. Supplementary Tables 1 and 2.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3055bd0a9e76aae19031eba7ae4367

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.